I 
118TH CONGRESS 
2D SESSION H. R. 10484 
To direct the Secretary of Health and Human Services to carry out a 
public awareness campaign to increase participation by women in clinical 
trials that are conducted or supported by the National Institutes of 
Health, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 18, 2024 
Mr. GOTTHEIMER (for himself and Ms. PETTERSEN) introduced the following 
bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To direct the Secretary of Health and Human Services to 
carry out a public awareness campaign to increase par-
ticipation by women in clinical trials that are conducted 
or supported by the National Institutes of Health, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Securing Equal Access 
to Research, Care, and Health Act of 2024’’ or the 
‘‘SEARCH Act of 2024’’. 
VerDate Sep 11 2014 
04:04 Jan 24, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H10484.IH
H10484
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 2. PUBLIC AWARENESS CAMPAIGN TO INCREASE PAR-
TICIPATION OF WOMEN IN NIH CLINICAL 
TRIALS. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (in this Act referred to as the ‘‘Sec-
retary’’), acting through the Director of the National In-
stitutes of Health, shall carry out a public awareness cam-
paign to increase the participation of women in clinical 
trials conducted or supported by the National Institutes 
of Health. 
(b) TARGETED OUTREACH.—In carrying out the 
campaign under subsection (a), the Secretary shall in-
crease outreach at hospitals, physicians’ offices, health 
centers, health care clinics, and other locations that the 
Secretary determines appropriate. 
(c) PRIORITY.—In carrying out the campaign under 
subsection (a), the Secretary shall prioritize increasing the 
participation of women in clinical trials involving research 
on, and development of, products to prevent, diagnose, or 
treat, rare diseases and conditions. 
(d) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$10,000,000 for each of fiscal years 2025 through 2029. 
VerDate Sep 11 2014 
04:04 Jan 24, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H10484.IH
H10484
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 3. PUBLIC AWARENESS CAMPAIGN TO INCREASE 
AWARENESS OF BLEEDING AND CLOTTING 
DISORDERS IN WOMEN. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services shall carry out a public awareness cam-
paign to increase the number of women participating in 
programs of the Department of Health and Human Serv-
ices for research, surveillance, and prevention with respect 
to bleeding and clotting disorders, including hemophilia. 
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$10,000,000 for each of fiscal years 2025 through 2029. 
SEC. 4. INTERAGENCY TASK FORCE ON ADVANCING TREAT-
MENTS FOR RARE DISEASES. 
Part A of title III of the Public Health Service Act 
(42 U.S.C. 241 et seq.) is amended by adding at the end 
the following: 
‘‘SEC. 310C. INTERAGENCY TASK FORCE ON ADVANCING 
TREATMENTS FOR RARE DISEASES. 
‘‘(a) IN GENERAL.—The Secretary shall maintain a 
permanent task force, to be known as the Interagency 
Task Force on Advancing Treatments for Rare Diseases 
(in this section referred to as the ‘Task Force’). The Sec-
retary shall establish the Task Force not later than 90 
days after the date of enactment of the SEARCH Act of 
2024. 
VerDate Sep 11 2014 
04:04 Jan 24, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H10484.IH
H10484
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(b) COMPOSITION.—The Task Force shall be com-
posed of the following members: 
‘‘(1) The Secretary. 
‘‘(2) The Administrator of the Centers for 
Medicare & Medicaid Services. 
‘‘(3) The Commissioner of Food and Drugs. 
‘‘(4) The Director of the National Institutes of 
Health. 
‘‘(5) The Director of the Centers for Disease 
Control and Prevention. 
‘‘(6) Four individuals, to be appointed by the 
Secretary, who are— 
‘‘(A) biopharmaceutical innovators with re-
spect to rare diseases and conditions; 
‘‘(B) private health plan administrators; or 
‘‘(C) representatives of institutions or or-
ganizations conducting federally funded re-
search with respect to rare diseases and condi-
tions. 
‘‘(7) Four individuals, to be appointed by the 
Secretary, who are representatives of rare disease 
advocacy groups. 
‘‘(c) DUTIES.—The Task Force shall— 
‘‘(1) assess— 
VerDate Sep 11 2014 
04:04 Jan 24, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H10484.IH
H10484
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(A) Federal agency activities concerning 
rare diseases, including projects involving two 
or more agencies; 
‘‘(B) overall programmatic funding; and 
‘‘(C) potential measurable outcomes to in-
clude in future reports; and 
‘‘(2) coordinate the efforts of the Department 
of Health and Human Services to incentivize re-
search on, and development of, products for preven-
tion, diagnosis, and treatment with respect to rare 
diseases and conditions, particularly rare diseases 
and 
conditions 
that 
disproportionately 
impact 
women.’’. 
SEC. 5. ACTION PLAN FOR COORDINATING HHS EFFORTS 
WITH RESPECT TO CERTAIN RARE DISEASES 
AND CONDITIONS. 
(a) IN GENERAL.—The Secretary shall prepare an 
action plan for coordinating efforts of the Department of 
Health and Human Services to incentivize research on, 
and development of, products for prevention, diagnosis, 
and treatment with respect to rare diseases and conditions 
that disproportionately impact women. 
(b) SUBMISSION AND PUBLIC AVAILABILITY.—Not 
later than 180 days after the date of enactment of this 
Act, the Secretary shall— 
VerDate Sep 11 2014 
04:04 Jan 24, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H10484.IH
H10484
ssavage on LAPJG3WLY3PROD with BILLS
(1) complete the action plan required by sub-
section (a); 
(2) submit such action plan to the Congress; 
and 
(3) make such plan publicly available, including 
by posting on the websites of the Department of 
Health and Human Services and the National Insti-
tutes of Health. 
Æ 
VerDate Sep 11 2014 
04:04 Jan 24, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H10484.IH
H10484
ssavage on LAPJG3WLY3PROD with BILLS